Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Psychiatric and neurologic disorders and cardiovascular disease Neurologic Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by